Table 5.
Age (Year) | NoS | NoP Tested | Effect Size | Heterogeneity I2, P | 95% CI | P |
---|---|---|---|---|---|---|
0 | 3 a | 488 | −0.192 | I2 = 93.2%, P = 0.0001 | −0.466 to +0.081 | 0.168 |
0.5 | 2 b | 361 | −0.157 | I2 = 97.1%, P = <0.0001 | −0.447 to +0.133 | 0.290 |
1 | 3 a | 459 | −0.422 | I2 = 96.7%, P = <0.0001 | −0.672 to −0.173 | <0.001 |
1.5 | 2 b | 361 | −0.629 | I2 = 85.8%, P = 0.008 | −0.735 to −0.522 | <0.0001 |
2 | 3 a | 500 | −0.646 | I2 = 90.9%, P = <0.0001 | −0.787 to −0.505 | <0.0001 |
2.5 | 2 b | 361 | −0.661 | I2 = 55.78%, P = 0.133 | −0.718 to −0.603 | <0.0001 |
3 | 3 a | 505 | −0.566 | I2 = 72.9%, P = 0.014 | −0.649 to −0.484 | <0.0001 |
3.5 | 2 b | 361 | −0.470 | I2 = 63.3%, P = 0.099 | −0.543 to −0.397 | <0.0001 |
4 | 3 a | 497 | −0.493 | I2 = 0.0%, P = 0.819 | −0.519 to −0.468 | <0.0001 |
4.5 | 2 b | 361 | −0.539 | I2 = 80.3%, P = 0.024 | −0.630 to −0.447 | <0.0001 |
5 | 3 a | 497 | −0.467 | I2 = 22.0%, P = 0.184 | −0.507 to −0.427 | <0.0001 |
5.5 | 2 b | 361 | −0.439 | I2 = 74.1%, P = 0.050 | −0.519 to −0.360 | <0.0001 |
6 | 3 a | 491 | −0.462 | I2 = 90.4%, P = 0.015 | −0.605 to −0.320 | <0.0001 |
7 | 2c | 409 | −0.464 | I2 = 24.8%, P = 0.249 | −0.535 to −0.393 | <0.0001 |
8 | 2 c | 399 | −0.444 | I2 = 69.2%, P = 0.071 | −0.598 to −0.291 | <0.0001 |
9 | 2 c | 400 | −0.491 | I2 = 94.3%, P = <0.0001 | −0.843 to −0.139 | 0.006 |
10 | 2 c | 399 | −0.400 | I2 = 91.3%, P = 0.0007 | −0.672 to −0.127 | 0.004 |
11 | 2c | 376 | −0.286 | I2 = 73.4%, P = 0.053 | −0.460 to −0.112 | <0.001 |
12 | 2 c | 388 | −0.338 | I2 = 63.0%, P = 0.100 | −0.479 to −0.197 | <0.0001 |
13 | 2 c | 372 | −0.376 | I2 = 0.0%, P = 0.381 | −0.413 to −0.339 | <0.0001 |
14 | 2 c | 379 | −0.438 | I2 = 50.4%, P = 0.156 | −0.550 to −0.327 | <0.0001 |
15 | 2 c | 365 | −0.450 | I2 = 66.7%, P = 0.083 | −0.608 to −0.292 | <0.0001 |
16 | 2 c | 374 | −0.524 | I2 = 0.0%, P = 0.541 | −0.562 to −0.486 | <0.0001 |
17 | 2 c | 362 | −0.642 | I2 = 0.0%, P = 0.946 | −0.688 to −0.597 | <0.0001 |
18 | 2 c | 352 | −0.842 | I2 = 0.0%, P = 0.863 | −0.906 to −0.777 | <0.0001 |
NoS: number of studies; NoP: number of patients; CI: confidence interval. References a Schaefer et al., 1994 [20], Aldámiz-Echevarría et al., 2014 [31], Thiele et al., 2017 [32]; b Schaefer et al., 1994 [20], Aldámiz-Echevarría et al., 2014 [31]; c Aldámiz-Echevarría et al., 2014 [31], Thiele et al., 2017 [32].